476 related articles for article (PubMed ID: 17891366)
21. The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination.
Maione F; Oliaro-Bosso S; Meda C; Di Nicolantonio F; Bussolino F; Balliano G; Viola F; Giraudo E
Sci Rep; 2015 Mar; 5():9054. PubMed ID: 25761781
[TBL] [Abstract][Full Text] [Related]
22. The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages.
Yang Y; Andersson P; Hosaka K; Zhang Y; Cao R; Iwamoto H; Yang X; Nakamura M; Wang J; Zhuang R; Morikawa H; Xue Y; Braun H; Beyaert R; Samani N; Nakae S; Hams E; Dissing S; Fallon PG; Langer R; Cao Y
Nat Commun; 2016 May; 7():11385. PubMed ID: 27150562
[TBL] [Abstract][Full Text] [Related]
23. Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth.
Bansal R; Tomar T; Ostman A; Poelstra K; Prakash J
Mol Cancer Ther; 2012 Nov; 11(11):2419-28. PubMed ID: 22933708
[TBL] [Abstract][Full Text] [Related]
24. The biology of integrins.
Stupack DG
Oncology (Williston Park); 2007 Aug; 21(9 Suppl 3):6-12. PubMed ID: 17927025
[TBL] [Abstract][Full Text] [Related]
25. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy.
Hall AP
Toxicol Pathol; 2006; 34(6):763-75. PubMed ID: 17162534
[No Abstract] [Full Text] [Related]
26. Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression.
Goto H; Nishioka Y
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286323
[TBL] [Abstract][Full Text] [Related]
27. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation.
Garmy-Susini B; Jin H; Zhu Y; Sung RJ; Hwang R; Varner J
J Clin Invest; 2005 Jun; 115(6):1542-51. PubMed ID: 15902308
[TBL] [Abstract][Full Text] [Related]
28. Tumor-derived mural-like cells coordinate with endothelial cells: role of YKL-40 in mural cell-mediated angiogenesis.
Francescone R; Ngernyuang N; Yan W; Bentley B; Shao R
Oncogene; 2014 Apr; 33(16):2110-22. PubMed ID: 23665676
[TBL] [Abstract][Full Text] [Related]
29. [Recent advances in pericytes angiogenic signaling pathways].
Lu WB; Shi XR; Xiu RJ
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):423-6. PubMed ID: 21914358
[No Abstract] [Full Text] [Related]
30. The basement membrane matrix in malignancy.
Engbring JA; Kleinman HK
J Pathol; 2003 Jul; 200(4):465-70. PubMed ID: 12845613
[TBL] [Abstract][Full Text] [Related]
31. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
[TBL] [Abstract][Full Text] [Related]
32. Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro.
Magnusson PU; Looman C; Ahgren A; Wu Y; Claesson-Welsh L; Heuchel RL
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2142-9. PubMed ID: 17656670
[TBL] [Abstract][Full Text] [Related]
33. PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival.
Song S; Ewald AJ; Stallcup W; Werb Z; Bergers G
Nat Cell Biol; 2005 Sep; 7(9):870-9. PubMed ID: 16113679
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of lycopene on PDGF-BB-induced signalling and migration in human dermal fibroblasts: a possible target for cancer.
Wu WB; Chiang HS; Fang JY; Hung CF
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1377-8. PubMed ID: 17956356
[TBL] [Abstract][Full Text] [Related]
35. Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling.
Liu G; Chen Y; Qi F; Jia L; Lu XA; He T; Fu Y; Li L; Luo Y
J Pathol; 2015 Oct; 237(2):190-202. PubMed ID: 25988668
[TBL] [Abstract][Full Text] [Related]
36. Targeting the tumor stroma in cancer therapy.
Anton K; Glod J
Curr Pharm Biotechnol; 2009 Feb; 10(2):185-91. PubMed ID: 19199950
[TBL] [Abstract][Full Text] [Related]
37. Analysis of mural cell recruitment to tumor vessels.
Abramsson A; Berlin O; Papayan H; Paulin D; Shani M; Betsholtz C
Circulation; 2002 Jan; 105(1):112-7. PubMed ID: 11772885
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases.
Chantrain CF; Henriet P; Jodele S; Emonard H; Feron O; Courtoy PJ; DeClerck YA; Marbaix E
Eur J Cancer; 2006 Feb; 42(3):310-8. PubMed ID: 16406506
[TBL] [Abstract][Full Text] [Related]
39. The tumour microenvironment: a novel target for cancer therapy.
Hanna E; Quick J; Libutti SK
Oral Dis; 2009 Jan; 15(1):8-17. PubMed ID: 18992016
[TBL] [Abstract][Full Text] [Related]
40. The role of the microenvironment and intercellular cross-talk in tumor angiogenesis.
Jung YD; Ahmad SA; Liu W; Reinmuth N; Parikh A; Stoeltzing O; Fan F; Ellis LM
Semin Cancer Biol; 2002 Apr; 12(2):105-12. PubMed ID: 12027582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
